Table 1. Main epidemiologic and clinical features of 13 cases of Trichophyton mentagrophytes genotype VII infections diagnosed in Paris, France, 2021–2022*.

Pt no.	Age, y	HIV+	PrEP	STI history	Travel	Tinea genitalis	Tinea glutealis	Tinea corporis	Tinea faciei/barbae	Prior treatment	T. mentagrophytes treatment
1†	45	No	Yes	Ng, Ct, Mg	No	No	Yes	Yes	Yes	No	TRB 1 mo
2	34	No	Yes	Ng	EE	No	Yes	Yes	Yes	ECZ, TS	TRB 5 d, then ITR 200 mg 1 mo, then ITR 100 mg 1 mo
3	28	No	No	ND	ND	Yes	No	Yes	No	No	TRB 4 mo + BFZ 1 mo
4	59	Yes	NA	Ng, Ct, Mg, Tp, HCV	No	Yes	Yes	Yes	Yes	No	TRB 2 mo + ECZ
5‡	39	Yes	NA	Tp	ND	Yes	Yes	Yes	Yes	No	TRB + CPX 3 wk
6‡	41	Yes	NA	Tp	ND	No	Yes	Yes	Yes	No	TRB + CPX 3 wk
7	40	No	Yes	Ng, Ct, Tp	No	No	No	No	Yes	PRI + MPC	TRB 6 wk
8	48	Yes	NA	Ng, Ct, Tp, Ss	No	No	No	Yes	No	No	CPX 4 wk
9‡	26	Yes	NA	Ng, Ct, Tp	ND	Yes	Yes	Yes	No	No	ECZ 6 wk
10‡§	35	No	Yes	Tp	ND	No	No	Yes	No	No	ECZ 6 wk
11§	22	No	Yes	Ng, Ct, Tp	DE	No	Yes	Yes	Yes	AMX then FLC	TRB 4 wk
12	35	Yes	NA	Ng,Tp	IN	No	No	Yes	No	TS then CPX	BFZ 4 wk
13	46	Yes	NA	Ng, Ct, Tp, Ss	ES	No	No	No	Yes	FCD + TS then FCD alone then PRI then AMX/CLAV	ITR 100 mg 2 d, then IV VRC 10 d, then TRB

*AMX, amoxicillin; BFZ, bifonazole; CLAV, clavulanic acid; CPX, ciclopirox olamine; Ct, Chlamydia trachomatis; DE, German; ECZ, econazole; EE, Estonia; ES, Spain; FCD, fucidin; FLC, fluconazole; HCV, hepatitis C virus; IN, India; ITR, itraconazole; Mg, Mycoplama genitalium; MPC, mupirocin; NA, not applicable; ND, no data; Ng; Neisseria gonorrheae; PrEP, pre-exposure prophylaxis; PRI, pristinamycin; Pt, patient; Ss, Sarcoptes scabiei; Tp, Treponema pallidum; TRB, oral terbinafine (250 mg 1×/d); TS, topical steroids; VRC, voriconazole. †Patient 1 strain was included in a previous survey (11). ‡Patients 5 and 6 and patients 9 and 10 were partners. §Patients 10 and 11 were co-infected with monkeypox virus.